Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2- carboxylic acid in children

Acta Dermato-Venereologica

Volumn 78, Issue 1, 1998, Pages 31-35

  Meyerhöffer, Saskia ^b   Lindberg, Zuzana ^b   Häger, Anders ^a   Kågedal, Bertil ^a   Rosdahl, Inger ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Melanoma; Pigment precursors; Pigmentary disorders

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; CYSTEINYLDOPA;

ARTICLE; CHILD; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DRUG URINE LEVEL; FEMALE; HUMAN; MALE; MALIGNANT TRANSFORMATION; MELANOMA; NORMAL HUMAN; PIGMENTED NEVUS; PRIORITY JOURNAL; URINARY EXCRETION;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CYSTEINYLDOPA; FEMALE; HUMANS; INDOLES; MALE; MELANINS; NEVUS, PIGMENTED; SEX FACTORS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031914337     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015559850135797     Document Type: Article

References (17)

1. Prota G. Melanins and melanogenesis. London: Acad Press Inc; 1992.
2. Rorsman H, Agrup G, Falck B, Rosengren A-M, Rosengren E. Exposure to sunlight and urinary excretion of 5-S-cysteinyldopa. In: Riley V, ed. Pigment cell. Vol. 2. Basel: Karger; 1975. p. 284-289.
3. Stierner U, Rosdahl I, Augustsson A, Kågedal B. Urinary excretion of 5-S-cysteinyldopa in relation to skin type, UVB-induced erythema, and melanocyte proliferation in human skin. J Invest Dermatol 1988; 91: 506-510.
4. Agrup G, Agrup P, Andersson T, Hafström L, Hansson SC, Jacobsson S, et al. 5-Years' experience of 5-S-cysteinyldopa in melanoma diagnosis. Acta Derm Venereol (Stockh) 1979; 59: 381-388.
5. Wakamatsu K, Ito S, Fujita K. Melanin-related metabolites in urine of B16 melanoma-bearing mice. Acta Derm Venereol (Stockh) 1988; 68: 385-389.
6. Pavel S, Elzinga H, Muskiet FAJ, Smit JM, Mulder NH, Schraffordt Koops H. Eumelanin-related indolic compounds in the urine of treated melanoma patients. J Clin Chem Clin Biochem 1986; 24: 167-173.
7. Westerhof W, Pavel S, Kammeyer A, Beusenberg FD, Cormane R. Melanin-related metabolites as markers of the skin pigmentary system. J Invest Dermatol 1987; 89: 78-82.
8. Quaba AA, Wallace AF. The incidence of malignant melanoma (0-15 years of age) arising in "large" congenital nevocellular naevi. Plast Reconstr Surg 1986; 78: 174-179.
9. Swerdlow AJ, English JSC, Qiao Z. The risk of melanoma in patients with congenital naevi: A cohort study. J Am Acad Dermatol 1995; 32: 595-599.
10. Hanawa Y, Wakamatsu K, Ikeda S. Serum concentration of 5S-cysteinyldopa in pediatric patients with giant pigmented naevi. J Dermatol 1996; 23: 16-21.
11. Kågedal B, Lenner L, Årstrand K, Hansson C. The stability of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in human urine. Pigment Cell Res 1992; 2: 304-307.
12. Kågedal B, Källberg M, Årstrand K. Automated high-performance liquid chromatographic determination of 5-S-cysteinyl-3,4-dihydroxyphenylalanine in urine. J Chromatogr 1989; 473: 359-370.
13. Pavel S, Van der Slik W. Analysis of eumelanin-related indolic compounds in urine by HPLC with fluorimetric detection. J Chromatogr 1986; 375: 392-398.
14. Fang-Kircher SG. Comparison of sialic acids excretion in spot urines and 24-hour-urines of children and adults. Eur J Clin Chem Clin Biochem 1997; 35: 47-52.
15. Kågedal B, Sandström A, Tibbling G. Determination of a trivariate reference region for free thyroxine index, free triiodothyronine index, and thyrotropin from results obtained in a health survey of middle-aged women. Clin Chem 1978; 24: 1744-1750.
16. Wirestrand L-E, Hansson C, Rosengren E, Rorsman H. Melanocyte metabolites in the urine of people of different skin colour. Acta Derm Venereol (Stockh) 1985; 65: 345-348.
17. Agrup G, Hansson C, Juldorf F, Rorsman H, Rosengren A-M, Rosengren E. Excretion of 5-S-cysteinyldopa in humans with genetically dark skin. Acta Derm Venereol (Stockh) 1979; 59: 69-70.